Research Output per year
Fingerprint Dive into the research topics where Gina Vaccaro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 22 Similar Profiles
Esophageal Neoplasms
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Neoadjuvant Therapy
Medicine & Life Sciences
Chemoradiotherapy
Medicine & Life Sciences
Hepatocellular Carcinoma
Medicine & Life Sciences
Adenocarcinoma
Medicine & Life Sciences
Esophagectomy
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2007 2019
A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer
Kearney, M. R., Chen, E. Y., Vaccaro, G., Strother, J., Burt, A., Todd, K., Donovan, J., Kampa-Schittenhelm, K. M. & Lopez, C., Jan 1 2019, In : Anticancer Research. 39, 1, p. 245-252 8 p.Research output: Contribution to journal › Article
irinotecan
Colorectal Neoplasms
oxaliplatin
Neutropenia
Combination Drug Therapy
1
Citation
(Scopus)
Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design
Moehler, M., Ryu, M. H., Dvorkin, M., Lee, K. W., Coşkun, H., Wong, R., Chung, H. C., Poltoratsky, A., Tsuji, A., Yen, C. J., Muntean, A. S., Le Sourd, S., Vaccaro, G., Overton, L., Boku, N., Wainberg, Z. A., Patel, M., Sharma, M., Xiong, H., Conti, I. & 2 others, , Feb 1 2019, In : Future Oncology. 15, 6, p. 567-577 11 p.Research output: Contribution to journal › Article
Stomach Neoplasms
Esophagogastric Junction
Stomach
oxaliplatin
Maintenance
195
Citations
(Scopus)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
KEYNOTE-224 investigators, Jul 1 2018, In : The Lancet Oncology. 19, 7, p. 940-952 13 p.Research output: Contribution to journal › Article
Hepatocellular Carcinoma
pembrolizumab
sorafenib
Therapeutics
Disease Progression
24
Citations
(Scopus)
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
Abou-Alfa, G. K., Qin, S., Ryoo, B. Y., Lu, S. N., Yen, C. J., Feng, Y. H., Lim, H. Y., Izzo, F., Colombo, M., Sarker, D., Bolondi, L., Vaccaro, G., Harris, W. P., Chen, Z., Hubner, R. A., Meyer, T., Sun, W., Harding, J. J., Hollywood, E. M., Ma, J. & 7 others, , Jun 1 2018, In : Annals of Oncology. 29, 6, p. 1402-1408 7 p.Research output: Contribution to journal › Article
Arginine
Hepatocellular Carcinoma
Patient Care
Placebos
Survival
1
Citation
(Scopus)
Small Bowel Adenocarcinoma
Chen, E. Y. & Vaccaro, G., Jan 1 2018, In : Clinics in Colon and Rectal Surgery. 31, 5, p. 267-277 11 p.Research output: Contribution to journal › Article
Adenocarcinoma
Biliary Tract Neoplasms
Gastrointestinal Neoplasms
Delayed Diagnosis
Polyps